The first drug found to slow dementia onset has had trial results confirmed in what scientists say could “herald a new era” for people with Alzheimer’s.
Fortnightly injections of lecanemab significantly slowed signs of disease in patients with early stage Alzheimer’s and stalled memory decline.
Follow-up of 1,800 patients aged 50 to 90 after 18 months confirmed cognitive decline was slowed by 27%.
